Test Price
2,800 AEDโ Home Collection Available
MYH7 Distal Myopathy Type 1 (Laing Distal Myopathy) Gene Sequencing Test in UAE
Executive Summary & Core Metrics
The MYH7 Distal Myopathy Type 1 (Laing Distal Myopathy) Gene Sequencing Test delivers a definitive molecular diagnosis for early-onset distal muscle weakness through comprehensive analysis of the MYH7 gene coding region using Next-Generation Sequencing (NGS) with copy number variation (CNV) detection. This test is performed at an ISO 9001:2015 accredited laboratory (Cert: INT/EGQ/2509DA/3139) ensuring 99.9% diagnostic sensitivity.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance to interpret results within the context of your family and personal health history.
- Insurance: Direct Billing Verification available โ send your insurance card via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MYH7 Distal Myopathy Type 1 (Laing Distal Myopathy) Gene Sequencing Test analyses the entire coding region of the MYH7 gene using Next-Generation Sequencing (NGS) with copy number variation (CNV) detection, confirming a definitive molecular diagnosis for early-onset distal muscle weakness. This approach provides comprehensive coverage of the gene, including detection of large deletions and duplications that single-gene Sanger sequencing would miss.
| Feature | Our Test (NGS + CNV) | Closest Alternative (Single-gene Sanger) |
|---|---|---|
| Precision | Full gene coverage with large deletion/duplication analysis | Point mutations only; may miss large structural variants |
| Methodology | Targeted NGS with verified bioinformatics pipeline | Sanger sequencing of selected exons |
| Speed | 3โ4 weeks | 6โ8 weeks (laboratory dependent) |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics specialist, I emphasise that a genetic result โ whether positive or negative โ must be interpreted alongside your clinical presentation, family pedigree, and a thorough neuromuscular evaluation. A confirmed pathogenic MYH7 variant establishes the diagnosis and enables your care team to implement appropriate surveillance, cardiac monitoring, and genetic counselling for at-risk family members. Always discuss results with your treating physician before making any health decisions.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication and Treatment Guidance
โ ๏ธ Important: Do not discontinue or alter any prescribed medication โ including cardiac therapies or physiotherapy regimens โ without consulting your treating physician. This genetic test is a diagnostic tool and does not replace clinical judgment or treatment directives from your healthcare provider.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- The test must not be used as a standalone prognostic tool in asymptomatic minors without a verified family history and appropriate pre-test genetic counselling, in compliance with UAE regulations governing genetic testing in minors.
Emergency Red Flags โ Seek Immediate Care
- Sudden deterioration in respiratory muscle strength or difficulty breathing
- New-onset aspiration or choking episodes
- New cardiac arrhythmia or palpitations
- Loss of ambulation or acute worsening of muscle weakness
If you experience any of these symptoms, visit the nearest emergency department or call 998 immediately.
Patient FAQ & Clinical Guidance
1. How soon can I expect my MYH7 distal myopathy gene test results, and what do they actually mean for my muscle weakness?
Results are delivered in 3 to 4 weeks from sample receipt. A positive result confirms a pathogenic variant in the MYH7 gene, providing a definitive molecular diagnosis that helps your neurologist tailor follow-up care, cardiac surveillance, and family planning. A negative result does not completely rule out other genetic causes, and your physician may recommend additional testing based on your clinical picture.
2. Will my insurance cover the cost of this genetic test in the UAE?
Most UAE insurers require pre-authorization for genetic testing. Our team handles direct billing verification on your behalf โ simply send your insurance card via WhatsApp to +971 54 548 8731 before sample collection, and we will confirm your coverage and manage the billing process.
3. Is genetic counselling mandatory before taking the MYH7 test?
Yes, a pre-test genetic counselling session is required. This session documents your detailed family pedigree, explains the autosomal dominant inheritance pattern, and ensures you make an informed decision about testing yourself and identifying at-risk relatives who may benefit from predictive testing.
UAE Regulatory & Data Privacy Adherence
Your genomic data is protected under the following UAE federal laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ governing the collection, processing, and storage of your personal and genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ regulating health information systems and electronic medical records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ ensuring clinical safety and informed consent standards are met throughout the testing process.
Your identifiable genetic data is never shared with third parties without your explicit written consent. All laboratory processes comply with DHA standards and international best practices for genomic data security.
Clinical & Logistical Metadata
| Test Name | MYH7 Distal Myopathy Type 1 (Laing Distal Myopathy) Gene Sequencing Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3โ5 mL in EDTA tube); VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) with CNV detection; ISO 9001:2015 accredited bioinformatics pipeline |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 94218-4 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians